FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs – Business Wire

Written by

in

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs Business Wire

View Best Offer

More posts

Canine cognition: Spirited Paw on designing pet brain health supplements for aging dogs – Nutrition Insight

March 19, 2026
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs – Business Wire

March 19, 2026
FDA expands parasiticide label to include 2 additional ticks – DVM360

March 19, 2026
Dog and Puppy Food Recalled Due to Salmonella Contamination – kinship.co

March 19, 2026